These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 13840861)

  • 1. [Favorable influence of 19-norandrostenolone phenylpropionate on the diabetic retinopathy].
    VALK LE
    Bull Mem Soc Fr Ophtalmol; 1959; 72():596-608. PubMed ID: 13840861
    [No Abstract]   [Full Text] [Related]  

  • 2. [ACTION OF NORANDROSTENOLONE PHENYLPROPIONATE IN DIABETIC RETINOPATHY].
    ROUHER F; SERPIN G
    Presse Med (1893); 1964 Sep; 72():2211-2. PubMed ID: 14186318
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical use of norandrostenolone phenylpropionate].
    VAN OS H; DEMEULEMEESTER J
    Bull Soc Sci Med Grand Duche Luxemb; 1959 Oct; 96():287-307. PubMed ID: 13841117
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of norandrostenolone phenylpropionate on the riboflavin content of blood.
    MARKKANEN T
    Ann Med Intern Fenn; 1962; 51():125-7. PubMed ID: 14469994
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preliminary clinical trials with the phenylpropionate of norandrostenolone (PPNA) as a protein anabolizing agent].
    HUGUENARD P; GODARD H
    Therapie; 1959; 14():738-44. PubMed ID: 14403896
    [No Abstract]   [Full Text] [Related]  

  • 6. [Action of norandrostenolone phenylpropionate (N.A.P.P.) in experimental tumorization].
    VERNE J; ROTH PC
    Bull Assoc Fr Etud Cancer; 1961; 48():535-7. PubMed ID: 13925515
    [No Abstract]   [Full Text] [Related]  

  • 7. Favourable effect of durabolin (19-nor-androstenolon-phenyl-propionate) on diabetic retinopathy.
    BEAUMONT P; vd BOOGAARD J
    Ophthalmologica; 1960 Jun; 139():480-4. PubMed ID: 13797980
    [No Abstract]   [Full Text] [Related]  

  • 8. The clinical effect of norandrostenolone phenylpropionate (durabolin) in metastasizing mammary cancer patients.
    MALMIO K; HISI-BRUMMER L; HORTLING H
    Ann Med Intern Fenn; 1960; 49():121-29. PubMed ID: 14420398
    [No Abstract]   [Full Text] [Related]  

  • 9. [Importance of norandrostenolone phenylpropionate in psychiatric therapy].
    BOITTELLE G; BOITTELLE-LENTULO C; DUMEZIL C
    Ann Med Psychol (Paris); 1962 Feb; 120(1)():389-92. PubMed ID: 13870704
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of diabetic retinopathy with nortestosterone phenylproprionate (Durabolin, Norabol).
    NORSKOV K
    Acta Ophthalmol (Copenh); 1961; 39():18-26. PubMed ID: 13729613
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of norandrostenolone phenylpropionate on growth and balance experiments in children.
    LAMBRECHTS A; JADOUL R
    Acta Endocrinol Suppl (Copenh); 1961; (Suppl 63)():111-23. PubMed ID: 14461781
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical and biochemical effects of nandrolone phenilpropionate (durabolin) and nandrolone decanoate (deca-durabolin) in diabetic retinopathies].
    HOUTSMULLER AJ; HENKES HE
    Ber Zusammenkunft Dtsch Ophthalmol Ges; 1961; 63():57-62. PubMed ID: 14449333
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of testosterone propionate and of norandrostenolone phenylpropionate on pituitary gonadotropin content in adult rats].
    PERUZY AD; LUCHETTI L; MARINOSCI A
    Folia Endocrinol Mens Incretologia Incretoterapia; 1959 Dec; 12():808-13. PubMed ID: 14432096
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetic retinopathy treated with testosterone.
    BEDROSSIAN RH; POCOCK DS; HARVEY WF; SINDONI AS
    AMA Arch Ophthalmol; 1953 Sep; 50(3):277-81. PubMed ID: 13079363
    [No Abstract]   [Full Text] [Related]  

  • 15. Norandrostenolone phenylpropionate and norandrostenolone decanoate in the treatment of metastasizing mammary carcinoma.
    HORTLING H; MALMIO K; HIISI-BRUMMER L
    Acta Endocrinol Suppl (Copenh); 1961; (Suppl 63)():132-42. PubMed ID: 14449065
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of the anabolic action of 19-nortestosterone phenylpropionate. Preliminary note].
    de SALCEDO ; BORGES F; GODINHO P
    J Med (Oporto); 1960 Nov; 43():599-600. PubMed ID: 13831238
    [No Abstract]   [Full Text] [Related]  

  • 17. [STUDIES ON MONGOLISM AND ITS TREATMENT WITH NORANDROSTENOLONE PHENYLPROPIONATE].
    SANTALO M; ECHEVARNE F
    Med Welt; 1963 Aug; 34():1683-6. PubMed ID: 14045056
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of durabolin (19-nor-androstenolone phenylpropionate) in the therapy of progressive muscular dystrophy].
    BEKENY G; KRAFT F; LANG S
    Orv Hetil; 1960 Feb; 101():229-34. PubMed ID: 13798373
    [No Abstract]   [Full Text] [Related]  

  • 19. [The use of durabolin (19-nor-androstenolone phenylpropionate) in the therapy of progressive muscular dystrophy].
    BEKENY G; KRAFT F; LANG S
    Nervenarzt; 1960 Mar; 31():118-23. PubMed ID: 13798372
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of norandrosterolone phenylpropionate (durabolin) in growth retardation in children].
    BARTA ; CSERE M; NABRADY J
    Gyermekgyogyaszat; 1960 Sep; 11():262-8. PubMed ID: 14448494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.